Epic Sciences is a San Diego, California clinical diagnostics company founded in 2008 that develops blood-based "liquid biopsy" tests for oncology. Its platform, licensed from the Peter Kuhn laboratory at Scripps Research, isolates and characterizes rare circulating tumor cells (CTCs) from whole blood using specialized assays and digital pathology algorithms, and is paired with circulating tumor DNA (ctDNA) sequencing to inform treatment selection and track how a tumor evolves. Its lead product, DefineMBC, is a comprehensive blood biopsy for metastatic breast cancer whose 56-gene ctDNA panel received Medicare coverage in April 2023. The company also runs its platform as a service for pharmaceutical partners measuring outcomes in clinical trials, and in 2020 partnered with Predicine to combine CTC and ctDNA analysis in a single offering. Epic Sciences is privately held and has raised roughly $204M across seven rounds through a Series G in April 2023. It is a laboratory diagnostics provider, not a software vendor, and publishes no public API, developer program, SDK or machine-readable specification.
Epic Sciences is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Diagnostics, Oncology, and Life Sciences.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: epic-sciences
name: Epic Sciences
description: Epic Sciences is a San Diego, California clinical diagnostics company founded in 2008 that develops blood-based
"liquid biopsy" tests for oncology. Its platform, licensed from the Peter Kuhn laboratory at Scripps Research, isolates
and characterizes rare circulating tumor cells (CTCs) from whole blood using specialized assays and digital pathology algorithms,
and is paired with circulating tumor DNA (ctDNA) sequencing to inform treatment selection and track how a tumor evolves.
Its lead product, DefineMBC, is a comprehensive blood biopsy for metastatic breast cancer whose 56-gene ctDNA panel received
Medicare coverage in April 2023. The company also runs its platform as a service for pharmaceutical partners measuring outcomes
in clinical trials, and in 2020 partnered with Predicine to combine CTC and ctDNA analysis in a single offering. Epic Sciences
is privately held and has raised roughly $204M across seven rounds through a Series G in April 2023. It is a laboratory
diagnostics provider, not a software vendor, and publishes no public API, developer program, SDK or machine-readable specification.
url: https://raw.githubusercontent.com/api-evangelist/epic-sciences/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
- url: https://epicsciences.com
status: 301
note: declared website redirects to https://www.stylekitchennashville.com/ — a different registrable domain (epicsciences.com
-> stylekitchennashville.com), possible rename or acquisition (probed 2026-09-03, roadmap#169)
generated: '2026-09-02'
method: derived
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Healthcare
- Diagnostics
- Oncology
- Life Sciences
- Biotechnology
- Laboratory
- Precision Medicine
tags_raw:
- Company
- Health Care
- Diagnostics
- Oncology
- Life Sciences
- Biotechnology
- Laboratory
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/epic-sciences-domain-security.yml
- type: Website
url: https://epicsciences.com
x-enrichment:
date: '2026-08-12'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: defunct
detail: epicsciences.com — the site every third-party record still lists as the company website — serves a blanket HTTP
301 to an unrelated third-party domain (awaji-musicisland.com) on every path including /robots.txt and every /.well-known/
location, and the domain publishes no MX, SPF, DMARC, CAA or DNSSEC records, so there is no live Epic Sciences web presence
left to profile, let alone a developer surface.
evidence:
- url: https://www.epicsciences.com/
status: 301
- url: https://www.epicsciences.com/.well-known/agent-card.json
status: 301
- url: https://www.epicsciences.com/openapi.json
status: 301
- url: https://api.github.com/orgs/epic-sciences
status: 404
checked: '2026-08-12'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.